The MCL Exchange: New Horizons in MCL: Clinical Advances and Trials
Are you aware of a new 1L treatment option for eligible MCL patients? Hear from Dr Faye Sharpley, Dr David Lewis & Dr Matthew Wilson.
Adverse events should be reported
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to AstraZeneca by visiting contactazmedical.astrazeneca.com or by calling 0800 783 0033.
September 2025 I GB-69434